1471 related articles for article (PubMed ID: 18758474)
21. Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo KF; Chang EH
Trends Biotechnol; 2008 Oct; 26(10):552-8. PubMed ID: 18722682
[TBL] [Abstract][Full Text] [Related]
22. Novel therapeutics for melanoma.
Seetharamu N; Ott PA; Pavlick AC
Expert Rev Anticancer Ther; 2009 Jun; 9(6):839-49. PubMed ID: 19496721
[TBL] [Abstract][Full Text] [Related]
23. Toxicity issues in cancer drug development.
Gewirtz DA; Bristol ML; Yalowich JC
Curr Opin Investig Drugs; 2010 Jun; 11(6):612-4. PubMed ID: 20496255
[TBL] [Abstract][Full Text] [Related]
24. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.
Schiffelers RM; Storm G
Int J Pharm; 2008 Dec; 364(2):258-64. PubMed ID: 18773947
[TBL] [Abstract][Full Text] [Related]
25. [Preclinical data as basis for the design of clinical studies].
Fichtner I
Onkologie; 2008; 31 Suppl 2():34-8. PubMed ID: 18487867
[TBL] [Abstract][Full Text] [Related]
26. Harnessing preclinical mouse models to inform human clinical cancer trials.
Gutmann DH; Hunter-Schaedle K; Shannon KM
J Clin Invest; 2006 Apr; 116(4):847-52. PubMed ID: 16585951
[TBL] [Abstract][Full Text] [Related]
27. Targeted drug delivery strategies to treat lung metastasis.
Bar J; Herbst RS; Onn A
Expert Opin Drug Deliv; 2009 Oct; 6(10):1003-16. PubMed ID: 19663628
[TBL] [Abstract][Full Text] [Related]
28. Radiation-guided drug delivery systems.
Stacy DR; Lu B; Hallahan DE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
[TBL] [Abstract][Full Text] [Related]
29. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
Patil Y; Sadhukha T; Ma L; Panyam J
J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
[TBL] [Abstract][Full Text] [Related]
30. Some thoughts on experimental screening.
Carter SK
Biomedicine; 1975 Jan; 22(1):5-17. PubMed ID: 1101978
[TBL] [Abstract][Full Text] [Related]
31. Improving the outcomes: developing cancer therapeutics.
Utku N
Future Oncol; 2012 Jan; 8(1):87-103. PubMed ID: 22149037
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle therapeutics: a personal perspective.
McNeil SE
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):264-71. PubMed ID: 20049796
[TBL] [Abstract][Full Text] [Related]
33. Rational combinations using HDAC inhibitors.
Bots M; Johnstone RW
Clin Cancer Res; 2009 Jun; 15(12):3970-7. PubMed ID: 19509171
[TBL] [Abstract][Full Text] [Related]
34. Epigenome-derived drugs: recent advances and future perspectives.
Vogiatzi P; Aimola P; Scarano MI; Claudio PP
Drug News Perspect; 2007 Dec; 20(10):627-33. PubMed ID: 18301797
[TBL] [Abstract][Full Text] [Related]
35. Improving the evaluation of new cancer treatments: challenges and opportunities.
Rothenberg ML; Carbone DP; Johnson DH
Nat Rev Cancer; 2003 Apr; 3(4):303-9. PubMed ID: 12671669
[TBL] [Abstract][Full Text] [Related]
36. Concept and clinical evaluation of carrier-mediated anticancer agents.
Zamboni WC
Oncologist; 2008 Mar; 13(3):248-60. PubMed ID: 18378535
[TBL] [Abstract][Full Text] [Related]
37. Cancer Therapy by Silver Nanoparticles: Fiction or Reality?
Kovács D; Igaz N; Gopisetty MK; Kiricsi M
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055024
[TBL] [Abstract][Full Text] [Related]
38. pH-responsive nanoparticles for cancer drug delivery.
Shen Y; Tang H; Radosz M; Van Kirk E; Murdoch WJ
Methods Mol Biol; 2008; 437():183-216. PubMed ID: 18369970
[TBL] [Abstract][Full Text] [Related]
39. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
40. Quantum dots: a powerful tool for understanding the intricacies of nanoparticle-mediated drug delivery.
Delehanty JB; Boeneman K; Bradburne CE; Robertson K; Medintz IL
Expert Opin Drug Deliv; 2009 Oct; 6(10):1091-112. PubMed ID: 19691443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
